More recently, the study of TRPC5 KO mice and inhibition of TRPC5 channels by antagonist addressed the enhanced inflamed joint and hyperalgesia76, suggesting that functional modulation of TRPC 1/5 could be considered as therapeutic targets for RA. This evidence concerns the gene TRPC5 and rheumatoid arthritis.